ADRs End Mostly Higher, AstraZeneca and atai Life Sciences Trade Actively
2022年10月26日 - 07:42AM
Dow Jones News
By Denny Jacob
International stocks trading in New York closed mostly higher on
Tuesday.
The S&P/BNY Mellon index of American depositary receipts
edged up 1.4% to 123.62. The European index gained 1.5% to 121.37.
The Asian index ticked up 1.5% to 135.64. The Latin American index
ticked down 0.4% to 186.28, while the emerging-markets index moved
up 0.8% to 233.10.
AstraZeneca PLC was among those whose ADRs traded actively.
The pharmaceutical giant moved up 1.3% after the company said
that a Phase 3 trial of its Fasenra treatment for eosinophilic
esophagitis passed one dual-primary endpoint but failed the
other.
Clinical-stage biopharmaceutical company atai Life Sciences
gained 4.5% after it said it completed the enrollment of its Phase
2a clinical trial of PCN-101, a stereoisomer of ketamine being
developed for treatment-resistant depression, with topline results
expected around 2022 year-end.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
October 25, 2022 18:27 ET (22:27 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Astrazeneca (LSE:AZN)
過去 株価チャート
から 2 2024 まで 3 2024
Astrazeneca (LSE:AZN)
過去 株価チャート
から 3 2023 まで 3 2024